- Home
- About
- PsychU For You
- Topics
- Mental Health Disorders
- Agitation
- Bipolar Disorder
- Depression
- Pseudobulbar Affect (PBA)
- PTSD/Trauma
- Schizophrenia
- Substance Use Disorders
- Topics of Interest
- Care Coordination
- Digital Health
- Diversity, Equity, & Inclusion
- Health Care Policy, Quality & Payer Administration
- Long-Term Care
- Stigma
- Suicide Awareness
- Wellness
- Events
- Content
- Supporting Organizations
Virtual Event – Monoamine Theory In Depression: Implications For Disease & Treatment

Thank You For Attending Today’s Webinar
Please tell us what you thought about today’s presentation by taking the survey below:
About This Event
Virtual Event – Monoamine Theory In Depression: Implications For Disease & Treatment
This is a Virtual Event for PsychU members in Idaho, Utah, Montana, and San Diego, Riverside, Imperial and San Bernardino Counties, CA.
The learning objectives of this program are:
- Identify monoamine neurobiological pathways and potential role in emotional behaviors
- Review the Monoamine imbalance theory in Depression
- Discuss current paradigm of treatment options and the neurobiological theories behind treatments

Michael Aldape, PhD
Senior Medical Science Liaison

Sucharita Somkuwar, PhD, BPharm (OPDC)
Clinical & Scientific Liaison
Speakers Michael Aldape, PhD and Sucharita Somkuwar, PhD, BPharm are employees of Otsuka Pharmaceutical Development & Commercialization, Inc.